Lee Scott Golden Ptc Therapeutics, Inc. (PTCT) insider trading activity

Lee Scott Golden is EVP & CHIEF MEDICAL OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 92,428 shares of PTCT, which is worth approximately $6.96 Million. The most recent transaction as insider was on Jan 08, 2026, when has been sold 866 shares (Common Stock) at a price of $76.45 per share, resulting in proceeds of $66,205. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.4K

21.62% 3M change

17.52% 12M change

Total Value Held $6.96 Million

Lee Scott Golden Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2026	SELL Open market or private sale	$66,205 $76.45 p/Share	866 Reduced 0.93%	92,428 Common Stock
Jan 07 2026	SELL Open market or private sale	$49,742 $77.48 p/Share	642 Reduced 0.68%	93,294 Common Stock
Jan 06 2026	SELL Open market or private sale	$103,113 $76.95 p/Share	1,340 Reduced 1.41%	93,936 Common Stock
Jan 02 2026	BUY Grant, award, or other acquisition	-	18,750 Added 16.44%	95,276 Common Stock
Apr 02 2025	SELL Open market or private sale	$42,114 $46.95 p/Share	897 Reduced 1.17%	75,997 Common Stock
Feb 20 2025	SELL Open market or private sale	$48,215 $50.12 p/Share	962 Reduced 1.24%	76,894 Common Stock
Feb 19 2025	SELL Open market or private sale	$39,829 $50.1 p/Share	795 Reduced 1.01%	77,856 Common Stock

Jan 08 2025	SELL Open market or private sale	$53,311 $44.5 p/Share	1,198 Reduced 1.5%	78,651 Common Stock
Jan 07 2025	SELL Open market or private sale	$36,725 $45.34 p/Share	810 Reduced 1.0%	79,849 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	20,000 Added 19.87%	80,659 Common Stock
May 07 2024	SELL Open market or private sale	$5,743 $32.82 p/Share	175 Reduced 0.29%	59,813 Common Stock
Apr 02 2024	SELL Open market or private sale	$14,922 $28.37 p/Share	526 Reduced 0.87%	59,988 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	22,600 Added 27.19%	60,514 Common Stock
Jan 09 2024	SELL Open market or private sale	$35,537 $29.01 p/Share	1,225 Reduced 3.13%	37,914 Common Stock
Jan 08 2024	SELL Open market or private sale	$22,196 $28.64 p/Share	775 Reduced 1.94%	39,139 Common Stock

Also insider at

CVKD

Cadrenal Therapeutics, Inc.

Director

LSG

Lee Scott Golden

EVP & CHIEF MEDICAL OFFICER

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account